Ectonucleotidase: Difference between revisions

Content deleted Content added
A1candidate (talk | contribs)
Citation bot (talk | contribs)
Add: isbn. | Use this bot. Report bugs. | Suggested by Corvus florensis | #UCB_webform 416/3500
 
(19 intermediate revisions by 12 users not shown)
Line 1:
{{Purinergic signalling}}
'''Ectonucleotidases''' consist of families of [[nucleotide]] [[metabolizing]] [[enzymes]] that are expressed on the [[plasma membrane]] and have externally oriented active sites. These enzymes operate metabolize [[nucleotide]]s to [[nucleoside]]s. The contribution of ectonucleotidases in the modulation of [[purinergic signaling]] depends on the availability and preference of substrates and on cell and tissue distribution.<ref name=beldi/>
 
'''Ectonucleotidases''' consist of families of [[nucleotide]] [[metabolizing]] [[enzymes]] that are expressed on the [[plasma membrane]] and have externally oriented active sites. These enzymes operate metabolize [[nucleotide]]s to [[nucleoside]]s. The contribution of ectonucleotidases in the modulation of [[purinergic signaling]] depends on the availability and preference of substrates and on cell and tissue distribution.<ref name=beldi/>
 
== Classification ==
FamiliesSubfamilies of ectonucleotidases include: [[CD39]]/NTPDases (ecto-nucleotide triphosphate diphosphohydrolases), Nucleotide pyrophosphatase/phosphodiesterase (NPP)-type ecto-phosphodiesterases, alkaline phosphatases and ecto-5’-nucleotidases/[[CD73]].<ref name=beldi>{{cite journal|last=Beldi|first=G|coauthorsauthor2=Enjyoji, K; |author3=Wu, Y; |author4=Miller, L; |author5=Banz, Y; |author6=Sun, X; |author7= Robson, SC |title=The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.|journal=Frontiers in bioscience : a journal and virtual libraryBioscience|date=2008 Jan 1, 2008|volume=13|issue=13|pages=2588-6032588–603|pmid=17981736 |pmc=2892180 |doi=10.2741/2868}}</ref>
 
Families of ectonucleotidases include: [[CD39]]/NTPDases (ecto-nucleotide triphosphate diphosphohydrolases), Nucleotide pyrophosphatase/phosphodiesterase (NPP)-type ecto-phosphodiesterases, alkaline phosphatases and ecto-5’-nucleotidases/[[CD73]].<ref name=beldi>{{cite journal|last=Beldi|first=G|coauthors=Enjyoji, K; Wu, Y; Miller, L; Banz, Y; Sun, X; Robson, SC|title=The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.|journal=Frontiers in bioscience : a journal and virtual library|date=2008 Jan 1|volume=13|pages=2588-603|pmid=17981736}}</ref>
 
== Function ==
Ectonucleotidases produce key molecules for purine salvage and consequent replenishment of ATP stores within multiple cell types. Dephosphorylated nucleoside derivatives interact with membrane transporters to enable intracellular uptake. Ectonucleotidases modulate [[P2 receptor|P2]] purinergic signaling, and [[P1 receptors]].<ref>{{Citation|last1=Kukulski|first1=Filip|title=Chapter 9 - Impact of Ectoenzymes on P2 and P1 Receptor Signaling|date=2011-01-01|url=http://www.sciencedirect.com/science/article/pii/B9780123855268000096|work=Advances in Pharmacology|volume=61|pages=263–299|editor-last=Jacobson|editor-first=Kenneth A.|series=Pharmacology of Purine and Pyrimidine Receptors|publisher=Academic Press|language=en|doi=10.1016/b978-0-12-385526-8.00009-6|access-date=2020-11-28|last2=Lévesque|first2=Sébastien A.|last3=Sévigny|first3=Jean|pmid=21586362|isbn=9780123855268 |editor2-last=Linden|editor2-first=Joel}}</ref> In addition, ectonucleotidases generate extracellular adenosine, which abrogates nucleotide-mediated effects and activates adenosine receptors, often with opposing (patho-) physiological effects.<ref>{{cite journal|last=Roberts|first=V|author2=Stagg, J |author3=Dwyer, KM |title=The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation.|journal=Frontiers in Immunology|year=2014|volume=5|pages=64|pmid=24600452|doi=10.3389/fimmu.2014.00064|pmc=3927137|doi-access=free}}</ref>
 
Ectonucleotidases also produce the key molecules for purine salvage and consequent replenishment of ATP stores within multiple cell types. Dephosphorylated nucleoside derivatives interact with membrane transporters to enable intracellular uptake. Ectonucleotidases modulate [[P2 receptor|P2]] purinergic signaling. In addition, ectonucleotidases generate extracellular adenosine, which abrogates nucleotide-mediated effects and activates adenosine receptors, often with opposing (patho-) physiological effects.<ref name=beldi/>
 
== Adenosine generation ==
The first step in the production of adenosine involves the conversion of ATP/ADP to AMP. It is carried out by [[ENTPD1]], also known as CD39. The second step involves the conversion of AMP to adenosine. It is carried out by [[NT5E]], also known as CD73.<ref>{{cite journal|last=Eltzschig|first=Holger K.|coauthorsauthor2=Bonney, Stephanie K.; |author3=Eckle, Tobias |title=Attenuating myocardial ischemia by targeting A2B adenosine receptors|journal=Trends in Molecular Medicine|date=June 2013|volume=19|issue=6|pages=345–354|doi=10.1016/j.molmed.2013.02.005|urlpmid=http://www.sciencedirect.com/science/article/pii/S147149141300034823540714|pmc=3674126}}</ref>
 
The first step in the production of adenosine involves the conversion of ATP/ADP to AMP. It is carried out by [[ENTPD1]], also known as CD39. The second step involves the conversion of AMP to adenosine. It is carried out by [[NT5E]], also known as CD73.<ref>{{cite journal|last=Eltzschig|first=Holger K.|coauthors=Bonney, Stephanie K.; Eckle, Tobias|title=Attenuating myocardial ischemia by targeting A2B adenosine receptors|journal=Trends in Molecular Medicine|date=June 2013|volume=19|issue=6|pages=345–354|doi=10.1016/j.molmed.2013.02.005|url=http://www.sciencedirect.com/science/article/pii/S1471491413000348}}</ref>
 
== References ==
<references/>
 
{{Purinergics}}
 
[[Category:Hydrolases]]
[[Category:Purinergic signalling]]
 
 
{{Enzyme-stub}}